Old Mutual Global Investors UK Ltd. reduced its position in Orthofix International N.V. (NASDAQ:OFIX) by 24.6% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 6,078 shares of the medical device company’s stock after selling 1,981 shares during the period. Old Mutual Global Investors UK Ltd.’s holdings in Orthofix International N.V. were worth $282,000 as of its most recent SEC filing.
Other institutional investors have also recently added to or reduced their stakes in the company. Mason Street Advisors LLC purchased a new position in shares of Orthofix International N.V. in the first quarter worth approximately $159,000. State of Alaska Department of Revenue increased its position in shares of Orthofix International N.V. by 79.3% in the second quarter. State of Alaska Department of Revenue now owns 3,551 shares of the medical device company’s stock worth $165,000 after acquiring an additional 1,571 shares in the last quarter. Quantbot Technologies LP purchased a new position in shares of Orthofix International N.V. in the first quarter worth approximately $175,000. BNP Paribas Arbitrage SA increased its position in shares of Orthofix International N.V. by 68.9% in the first quarter. BNP Paribas Arbitrage SA now owns 4,656 shares of the medical device company’s stock worth $178,000 after acquiring an additional 1,900 shares in the last quarter. Finally, Municipal Employees Retirement System of Michigan purchased a new position in shares of Orthofix International N.V. in the second quarter worth approximately $196,000. 94.43% of the stock is currently owned by institutional investors and hedge funds.
Shares of Orthofix International N.V. (OFIX) opened at 49.38 on Tuesday. Orthofix International N.V. has a 12-month low of $32.51 and a 12-month high of $50.40. The firm has a market capitalization of $897.23 million, a PE ratio of 115.64 and a beta of 0.22. The company’s 50 day moving average is $47.07 and its 200 day moving average is $42.60.
Orthofix International N.V. (NASDAQ:OFIX) last posted its earnings results on Monday, August 7th. The medical device company reported $0.42 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.41 by $0.01. Orthofix International N.V. had a return on equity of 9.96% and a net margin of 1.88%. The business had revenue of $108.90 million during the quarter, compared to analysts’ expectations of $102.94 million. During the same period in the prior year, the business earned $0.41 EPS. Orthofix International N.V.’s revenue for the quarter was up 4.6% compared to the same quarter last year. On average, analysts forecast that Orthofix International N.V. will post $1.56 earnings per share for the current year.
Several research firms have recently weighed in on OFIX. Langenberg & Company reissued a “buy” rating and issued a $53.25 target price on shares of Orthofix International N.V. in a research report on Wednesday, June 14th. Jefferies Group LLC reissued a “buy” rating and issued a $55.00 target price (up from $50.00) on shares of Orthofix International N.V. in a research report on Thursday, August 10th. BidaskClub downgraded shares of Orthofix International N.V. from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, July 25th. BTIG Research began coverage on shares of Orthofix International N.V. in a research report on Wednesday, June 21st. They issued a “buy” rating and a $52.00 target price on the stock. Finally, Zacks Investment Research raised shares of Orthofix International N.V. from a “hold” rating to a “buy” rating and set a $54.00 target price on the stock in a research report on Thursday, August 10th. Seven investment analysts have rated the stock with a buy rating, The company presently has a consensus rating of “Buy” and a consensus price target of $52.75.
In related news, insider Raymond Fujikawa sold 6,364 shares of the stock in a transaction that occurred on Thursday, August 10th. The stock was sold at an average price of $47.06, for a total transaction of $299,489.84. Following the completion of the sale, the insider now directly owns 31,084 shares of the company’s stock, valued at approximately $1,462,813.04. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO Brad Mason sold 2,733 shares of the stock in a transaction that occurred on Monday, August 21st. The stock was sold at an average price of $48.10, for a total value of $131,457.30. Following the sale, the chief executive officer now directly owns 188,053 shares of the company’s stock, valued at $9,045,349.30. The disclosure for this sale can be found here. 5.60% of the stock is currently owned by corporate insiders.
ILLEGAL ACTIVITY NOTICE: This piece of content was first reported by Markets Daily and is owned by of Markets Daily. If you are reading this piece of content on another publication, it was copied illegally and reposted in violation of U.S. and international trademark & copyright laws. The correct version of this piece of content can be accessed at https://www.themarketsdaily.com/2017/09/12/old-mutual-global-investors-uk-ltd-has-282000-stake-in-orthofix-international-n-v-ofix.html.
About Orthofix International N.V.
Orthofix International N.V. (Orthofix) is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The company operates in four segments: BioStim, Biologics, Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim, Spinal-Stim and Physio-Stim.
Want to see what other hedge funds are holding OFIX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Orthofix International N.V. (NASDAQ:OFIX).
Receive News & Ratings for Orthofix International N.V. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthofix International N.V. and related companies with MarketBeat.com's FREE daily email newsletter.